Stay updated on ED-SCLC Immuno-Therapy Clinical Trial
Sign up to get notified when there's something new on the ED-SCLC Immuno-Therapy Clinical Trial page.

Latest updates to the ED-SCLC Immuno-Therapy Clinical Trial page
- Check7 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.2, representing a minor version update with no visible changes to the study details.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRecruitment status has been updated to indicate that no participants are being enrolled, signaling that enrollment is closed. The page also adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study) and adjusts the Intervention/Treatment label along with a revision tag.SummaryDifference0.2%

- Check28 days agoChange DetectedAdded Lung cancer as a topic and a related topics section, including a MedlinePlus Genetics reference. Updated the revision tag from v3.5.4 to v3.5.5.SummaryDifference0.1%

- Check43 days agoChange DetectedThe page loses certain background topic labels and the MedlinePlus Genetics link, reducing some background resources while keeping the study details and structure intact.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page now displays Revision: v3.5.4, replacing the previous Revision: v3.5.3, indicating a new version of the page content.SummaryDifference0.0%

- Check64 days agoChange DetectedAn updated study site listing appears as Taoyuan, Taiwan, 333, and the Taoyuan District listing is removed; the page also adds Lung cancer as a topic and includes related topics such as MedlinePlus Genetics.SummaryDifference0.1%

Stay in the know with updates to ED-SCLC Immuno-Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ED-SCLC Immuno-Therapy Clinical Trial page.